Research output per year
Research output per year
Personal profile
Academic discipline
MEDS-10/A - Gastroenterology
Fingerprint
Dive into the research topics where Alfredo Papa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country level (based on research outputs with Scopus ID). Dive into details by clicking on the dots.
-
Bowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: a prospective, international study
Tursi, A., Piovani, D., Brandimarte, G., Di Mario, F., Elisei, W., Picchio, M., Figlioli, G., Bassotti, G., Allegretta, L., Annunziata, M. L., Bafutto, M., Bianco, M. A., Colucci, R., Conigliaro, R., Dumitrascu, D. L., Escalante, R., Ferrini, L., Forti, G., Franceschi, M. & Graziani, M. G. & 26 others, , 2025, In: Intestinal Research. 23, 1, p. 96-106 11 p.Research output: Contribution to journal › Article
-
Cancer Risk in IBD Patients Treated with JAK Inhibitors: Reassuring Evidence from Trials and Real-World Data
Puca, P., Del Gaudio, A., Iaccarino, J., Blasi, V., Coppola, G., Laterza, L., Lopetuso, L. R., Colantuono, S., Gasbarrini, A., Scaldaferri, F. & Papa, A., 2025, In: Cancers. 17, 5, p. N/A-N/AResearch output: Contribution to journal › Article
-
Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools
Murgiano, M., Bartocci, B., Puca, P., di Vincenzo, F., Del Gaudio, A., Papa, A., Cammarota, G., Gasbarrini, A., Scaldaferri, F. & Lopetuso, L. R., 2025, In: International Journal of Molecular Sciences. 26, 7, p. N/A-N/AResearch output: Contribution to journal › Article
-
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected
Tursi, A., Mocci, G., Elisei, W., Savarino, E., Maconi, G., Scaldaferri, F. & Papa, A., 2025, In: Minerva Gastroenterology. 71, 1, p. 15-21 7 p.Research output: Contribution to journal › Article
-
Vascular complications in hospitalized patients with inflammatory bowel disease and acute gastroenteritis and colitis: A propensity score-matched study
Papa, A., Laterza, L., Papa, V., Lopetuso, L. R., Colantuono, S., Coppola, G., Simeoni, B., Scaldaferri, F., Franceschi, F., Gasbarrini, A. & Covino, M., 2025, In: Digestive and Liver Disease. 57, 5, p. 547-555 9 p.Research output: Contribution to journal › Article
Datasets
-
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
Guidi, L. (Creator), Pugliese, D. (Creator), Tonucci, T. P. (Creator), Bertani, L. (Creator), Costa, F. (Creator), Privitera, G. (Creator), Tolusso, B. (Creator), Di Mario, C. (Contributor), Albano, E. (Creator), Tapete, G. (Creator), Gremese, E. (Creator), Papa, A. (Creator), Gasbarrini, A. (Creator), Rapaccini, G. L. (Creator) & Armuzzi, A. (Creator), SAGE Journals, 2019
DOI: 10.25384/sage.c.4653497, https://sage.figshare.com/collections/Early_vedolizumab_trough_levels_predict_treatment_persistence_over_the_first_year_in_inflammatory_bowel_disease/4653497
Dataset
-
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
Guidi, L. (Creator), Pugliese, D. (Creator), Tonucci, T. P. (Creator), Bertani, L. (Creator), Costa, F. (Creator), Privitera, G. (Creator), Tolusso, B. (Creator), Di Mario, C. (Contributor), Albano, E. (Creator), Tapete, G. (Creator), Gremese, E. (Creator), Papa, A. (Creator), Gasbarrini, A. (Creator), Rapaccini, G. L. (Creator) & Armuzzi, A. (Creator), SAGE Journals, 2019
DOI: 10.25384/sage.c.4653497.v1, https://sage.figshare.com/collections/Early_vedolizumab_trough_levels_predict_treatment_persistence_over_the_first_year_in_inflammatory_bowel_disease/4653497/1
Dataset
-
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
Guidi, L. (Creator), Pugliese, D. (Creator), Tonucci, T. P. (Creator), Bertani, L. (Creator), Costa, F. (Creator), Privitera, G. (Creator), Tolusso, B. (Creator), Di Mario, C. (Contributor), Albano, E. (Creator), Tapete, G. (Creator), Gremese, E. (Creator), Papa, A. (Creator), Gasbarrini, A. (Creator), Rapaccini, G. L. (Creator) & Armuzzi, A. (Creator), SAGE Journals, 2019
DOI: 10.25384/sage.c.4653497.v1, https://sage.figshare.com/collections/Early_vedolizumab_trough_levels_predict_treatment_persistence_over_the_first_year_in_inflammatory_bowel_disease/4653497/1
Dataset
-
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study
Tursi, A. (Creator), Mocci, G. (Creator), Scaldaferri, F. (Creator), Napolitano, D. (Creator), Maresca, R. (Creator), Pugliese, D. (Creator), Semprucci, G. (Creator), Savarino, E. (Creator), Cuomo, A. (Creator), Donnarumma, L. (Creator), Bodini, G. (Creator), Pasta, A. (Creator), Maconi, G. (Creator), Cataletti, G. (Creator), Pranzo, G. (Creator), Rodinò, S. (Creator), Sebkova, L. (Creator), Costa, F. (Creator), Ferronato, A. (Creator), Gaiani, F. (Creator), Marzo, M. (Creator), Luppino, I. (Creator), Fabiano, G. (Creator), Paese, P. (Creator), Elisei, W. (Creator), Monterubbianesi, R. (Creator), Faggiani, R. (Creator), Grossi, L. (Creator), Serio, M. (Creator), Scarcelli, A. (Creator), Lorenzetti, R. (Creator), Allegretta, L. (Creator), Chiri, S. (Creator), Grasso, G. (Creator), Antonelli, E. (Creator), Bassotti, G. (Creator), Spagnuolo, R. (Creator), Luzza, F. (Creator), Fanigliulo, L. (Creator), Rocco, G. (Creator), Sacchi, C. (Creator), Zampaletta, C. (Creator), Rocchi, C. (Creator), Bolognini, L. (Creator), Bendia, E. (Creator), Bianco, M. A. (Creator), Capone, P. (Creator), Meucci, C. (Creator), Colucci, R. (Creator), Tonti, P. (Creator), Neve, V. (Creator), Della Valle, N. (Creator), Felice, C. (Creator), Pica, R. (Creator), Cocco, A. (Creator), Forti, G. (Creator), Onidi, F. M. (Creator), Usai Satta, P. (Contributor), Checchin, D. (Creator), Gravina, A. G. (Creator), Pellegrino, R. (Creator), Picchio, M. (Creator) & Papa, A. (Creator), Taylor & Francis, 2024
DOI: 10.6084/m9.figshare.25039971.v1, https://tandf.figshare.com/articles/dataset/Ustekinumab_safety_and_effectiveness_in_patients_with_ulcerative_colitis_results_from_a_large_real-life_study/25039971/1
Dataset
-
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
Guidi, L. (Creator), Pugliese, D. (Creator), Tonucci, T. P. (Creator), Bertani, L. (Creator), Costa, F. (Creator), Privitera, G. (Creator), Tolusso, B. (Creator), Di Mario, C. (Contributor), Albano, E. (Creator), Tapete, G. (Creator), Gremese, E. (Creator), Papa, A. (Creator), Gasbarrini, A. (Creator), Rapaccini, G. L. (Creator) & Armuzzi, A. (Creator), SAGE Journals, 2019
DOI: 10.25384/sage.c.4653497, https://sage.figshare.com/collections/Early_vedolizumab_trough_levels_predict_treatment_persistence_over_the_first_year_in_inflammatory_bowel_disease/4653497
Dataset